Jianqiang Qian

Jianqiang Qian

Auto-generated profile, based on publicly available information

Jianqiang Qian

School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong 226001. China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YLYong Ling
Yong Ling
JLJi Liu
Ji Liu
JQJianqiang Qian
Jianqiang Qian
CMChi Meng
Chi Meng
JGJing Guo
Jing Guo
YZYanan Zhang
Yanan Zhang
Protein Kinase Inhibitors (PKIs) and Histone Deacetylase Inhibitors (HDACIs) are two important classes of anticancer agents and have provided a variety of small molecule drugs for the treatment of various types of human cancers. However, malignant tumors are of a multifactorial nature that can hardly be “cured” by targeting a single target, and treatment of cancers hence requires modulation of multiple biological targets to restore the physiological balance and generate sufficient therapeutic efficacy. Multi-target drugs have attracted great interest because of their advantages in the treatment of complex cancers by simultaneously targeting multiple signaling pathways and possibly leading to synergistic effects. Synergistic effects have been observed in the combination of kinase inhibitors, such as imatinib, dasatinib, or sorafenib, with an array of HDACIs including vorinostat, romidepsin, or panobinostat. A considerable number of multi-target agents based on PKIs and HDACIs have been developed. In this review, we summarize the recent literature on the development of multi-target kinase-HDAC inhibitors and provide our view on the challenges and future directions on this topic.

19 August 2023 in Materials & Design
Verified
Journal Article
Open access
CMChi Meng
Chi Meng
XXXudong Xie
Xudong Xie
JQJianqiang Qian
Jianqiang Qian
WTWeizhi Tao
Weizhi Tao
HWHongmei Wu
Hongmei Wu
YLYong Ling
Yong Ling

1 October 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
JQJianqiang Qian
Jianqiang Qian
YGYaqin Gu
Yaqin Gu
ZWZihao Wang
Zihao Wang
MPMingshi Pan
Mingshi Pan
DLDingding Li
Dingding Li
JDJinfeng Ding
Jinfeng Ding